Mutations in DNM2 and MTM1 give rise to CNM phenotypes that greatly overlap with SPEG-related CNM (Table 1), including defects in triad formation and elevated levels or activity of DNM2. The gene discussed is MTM1; the disease is centronuclear myopathy.